Noom vs Push Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Push Health
Best for brand-name GLP-1 distribution via large pharmacy network (pending verification)Starting at $950/mo
Side-by-Side Comparison
| Feature | Noom | Push Health |
|---|---|---|
| Overall Score | 7.1/10 | 7.1/10 |
| Starting Price | — | $950/mo |
| Editorial Rating | 3.6 ★ /5 | 3.6 ★ /5 |
| Features | 2 features | ✓5 features |
| States Available | 0 | 0 |
| Compounded | — | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Noom
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Pricing not publicly disclosed
Push Health
Pros
- ✓Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
- ✓55,000+ pharmacy network per competitor sources
- ✓LegitScript certified per competitor sources
- ✓Listed in both competitor directories
Cons
- ✗Brand-name-only — no compounded option
- ✗Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
- ✗Confidence LOW until verified
Our Verdict
Both Noom and Push Health score equally well overall — the right choice depends on your priorities. Choose Noom if you want mainstream telehealth GLP-1 access, or Push Health if brand-name GLP-1 distribution via large pharmacy network (pending verification) matters most to you.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.